Professional Overview
Tracy Hernandez is a seasoned risk management executive with extensive experience in the pharmaceutical industry. As the Senior Director of Global Risk Management at Bristol Myers Squibb, she is responsible for overseeing the company's comprehensive risk mitigation strategies and ensuring compliance with industry regulations.
Experience Summary
Current Role
In her current position, Tracy leads a team of risk management professionals, developing and implementing robust risk assessment frameworks to proactively identify, analyze, and address potential threats to the organization. Her strategic risk management initiatives have contributed to Bristol Myers Squibb's ability to navigate complex regulatory environments and maintain a strong market position.
Career Progression
Prior to her role at Bristol Myers Squibb, Tracy served in various leadership positions at Celgene, where she progressed from Director of Global Risk Management Standards to Senior Director of Global Risk Management Operations. In these roles, she played a pivotal part in establishing and enhancing the company's risk management infrastructure, enabling it to effectively manage risks and ensure business continuity during a period of rapid growth and transformation.
Earlier in her career, Tracy held customer service and operational management roles at NAI Global and FITA, INC., honing her expertise in delivering exceptional service and optimizing organizational processes.
Academic Background
Tracy holds a Bachelor's degree in Business Administration from a reputable university, with a focus on Operations Management and Finance.
Areas of Expertise
- Comprehensive risk management strategy development and implementation
- Regulatory compliance and industry best practices
- Operational excellence and process optimization
- Cross-functional collaboration and team leadership
- Data-driven decision making and risk analytics
Professional Impact
During her tenure at Celgene, Tracy spearheaded the implementation of a centralized risk management platform, which enabled the organization to streamline risk identification, assessment, and mitigation efforts. As a result, the company experienced a significant reduction in risk-related incidents, contributing to its successful integration with Bristol Myers Squibb.
At Bristol Myers Squibb, Tracy's strategic leadership has been instrumental in enhancing the company's global risk management capabilities, allowing it to navigate the challenges of the evolving pharmaceutical landscape and maintain its position as an industry leader.
Conclusion
With her extensive experience, strong leadership skills, and commitment to excellence, Tracy Hernandez is a valuable asset to Bristol Myers Squibb. Her expertise in global risk management, coupled with her ability to drive organizational change and innovation, positions her as a trusted advisor and strategic partner in the pharmaceutical industry.
